Home
People
Research
Publications
Links
Contact
Funding
RSS Feed
Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
Sandro Santagata
December 9, 2018
«
New molecular targets in meningiomas: the present and the future.
Rapid discrimination of pediatric brain tumors by mass spectrometry imaging.
»
News & Events
Craniopharyngioma Trial Continues Enrollment
DRAMATIC CLINICAL RESPONSE TO PD-1 BLOCKADE IN MMR DEFICIENT HIGH-GRADE MENINGIOMA
GERMLINE AND SOMATIC BAP1 MUTATIONS IN HIGH GRADE MENINGIOMA.
HIGHLY MULTIPLEXED IMAGING OF HUMAN TISSUES
Molecular Margins with Metabolite Guide Brain Surgery
PIK3CA MUTATIONS IN MENINGIOMA
TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA
Top
